Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Connection

Justin Honce to Adult

This is a "connection" page, showing publications Justin Honce has written about Adult.

 
Connection Strength
 
 
 
0.179
 
  1. Sunshine A, Honce GH, Callen AL, Zander DA, Tanabe JL, Pisani Petrucci SL, Lin CT, Honce JM. Evaluating the Quality and Understandability of Radiology Report Summaries Generated by ChatGPT: Survey Study. JMIR Form Res. 2025 Aug 27; 9:e76097.
    View in: PubMed
    Score: 0.048
  2. Alvarez E, Nair KV, Hoyt BD, Seale RA, Sillau S, Miravalle A, Engebretson E, Schurr B, Corboy JR, Vollmer TL, Honce JM. Brain atrophy rates in patients with multiple sclerosis on long term natalizumab resembles healthy controls. Mult Scler Relat Disord. 2021 Oct; 55:103170.
    View in: PubMed
    Score: 0.036
  3. Honce JM, Nair KV, Sillau S, Valdez B, Miravalle A, Alvarez E, Schreiner T, Corboy JR, Vollmer TL. Rituximab vs placebo induction prior to glatiramer acetate monotherapy in multiple sclerosis. Neurology. 2019 02 12; 92(7):e723-e732.
    View in: PubMed
    Score: 0.030
  4. Heit JJ, Honce JM, Yedavalli VS, Baccin CE, Tatit RT, Copeland K, Timpone VM. RAPID Aneurysm: Artificial intelligence for unruptured cerebral aneurysm detection on CT angiography. J Stroke Cerebrovasc Dis. 2022 Oct; 31(10):106690.
    View in: PubMed
    Score: 0.010
  5. Pollard R, Leppert M, Rawson C, Boehnke M, Honce J, Nagae L, Poisson S, Nyberg E. A Clinical Paradigm for Classifying Neurologic Symptoms to Screen for Emergent Large Vessel Occlusions. J Stroke Cerebrovasc Dis. 2019 Apr; 28(4):929-934.
    View in: PubMed
    Score: 0.008
  6. Sakamoto MR, Honce JM, Lindquist DL, Camidge DR. Lorlatinib Salvages CNS Relapse in an ALK-Positive Non-Small-Cell Lung Cancer Patient Previously Treated With Crizotinib and High-Dose Brigatinib. Clin Lung Cancer. 2019 03; 20(2):e133-e136.
    View in: PubMed
    Score: 0.008
  7. Vollmer B, Honce JM, Sillau S, Corboy JR, Vollmer T, Nair K, Alvarez E. The impact of very short transition times on switching from Natalizumab to Fingolimod on imaging and clinical effectiveness outcomes in multiple sclerosis. J Neurol Sci. 2018 07 15; 390:89-93.
    View in: PubMed
    Score: 0.007
  8. Willard N, Honce JM, Kleinschmidt-DeMasters BK. PRES: Review of Histological Features. J Neuropathol Exp Neurol. 2018 Feb 01; 77(2):100-118.
    View in: PubMed
    Score: 0.007
  9. Kindred JH, Li K, Ketelhut NB, Proessl F, Fling BW, Honce JM, Shaffer WR, Rudroff T. Cannabis use in people with Parkinson's disease and Multiple Sclerosis: A web-based investigation. Complement Ther Med. 2017 Aug; 33:99-104.
    View in: PubMed
    Score: 0.007
  10. Nyberg EM, Case D, Nagae LM, Honce JM, Reyenga W, Seinfeld J, Poisson S, Leppert MH. The Addition of Endovascular Intervention for Dural Venous Sinus Thrombosis: Single-Center Experience and Review of Literature. J Stroke Cerebrovasc Dis. 2017 Oct; 26(10):2240-2247.
    View in: PubMed
    Score: 0.007
  11. Narayanan V, Honce MJ, Mehrotra S, Camidge DR. Cystic Brain Metastases Occurring in Anaplastic Lymphoma Kinase Gene Rearranged Non-Small-Cell Lung Cancer Patients Receiving Crizotinib. Clin Lung Cancer. 2016 Jan; 17(1):85-90.
    View in: PubMed
    Score: 0.006
  12. Regner MF, Dalwani M, Yamamoto D, Perry RI, Sakai JT, Honce JM, Tanabe J. Sex Differences in Gray Matter Changes and Brain-Behavior Relationships in Patients with Stimulant Dependence. Radiology. 2015 Dec; 277(3):801-12.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)